Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -5.60 (-1.69%)
Bid:
324.60
Ask:
325.40
Spread: 0.80 (0.246%)
Market Cap: £1.72b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Directorate Change

4 Mar 2022 07:01

RNS Number : 6122D
Hammerson PLC
04 March 2022
Β 

Hammerson plc ("Hammerson")

4 March 2022

Β 

Board changes

Β 

Hammerson announces that Andrew Formica, Non-Executive Director, has informed the Board that, having served 6 years on the Board, he will not stand for re-election at the 2022 Annual General Meeting and will step down at the conclusion of the meeting. Mr Formica was first appointed to the Board on 26 November 2015.

Β 

Hammerson also announces that Gwyn Burr, Senior Independent Director and Chair of the Remuneration Committee, will not stand for re-election at the 2022 Annual General Meeting and will step down at the conclusion of the meeting. Ms Burr was first appointed to the Board on 21 May 2012, and after 9 years' service, she originally planned to step down at the 2021 Annual General Meeting, but agreed to extend for a further year to provide continuity at a time of significant Board change.

Β 

Mike Butterworth, Non-Executive Director and Chair of the Audit Committee will succeed Ms Burr as Senior Independent Director and Habib Annous, Non-Executive Director, will succeed her as Chair of the Remuneration Committee.

Β 

Robert Noel, Chair of the Board commented: "Andrew and Gwyn have been engaged and effective members of the Board and have been particularly helpful over the last 18 months as the Board has been through significant change. On behalf of all the Board I would like to thank them for their service and contribution."

Β 

There are no further matters in connection with this appointment to be disclosed under Listing Rule 9.6.13.

Β 

ENDS

For further information:

Josh Warren, Director of Strategy and Investor Relations

Tel: 020 7887 1053

Β 

Alice Darwall, General Counsel and Company Secretary

Tel: 020 7887 1000

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAUOVKRUWUORAR
Date   Source Headline
5th Jun 20268:00 amRNSPublication of Final Terms
2nd Jun 20267:00 amRNSSuccessful pricing of 5-year EUR350m bond
29th May 20263:45 pmRNSHolding(s) in Company
26th May 202610:00 amRNSResults of Dividend Reinvestment Plan
22nd May 20264:15 pmRNSDirector/PDMR Shareholding
19th May 20262:00 pmRNSDirector/PDMR Shareholding
15th May 202612:30 pmRNSDirector/PDMR Shareholding
14th May 20263:00 pmRNSDirector/PDMR Shareholding
30th Apr 20264:30 pmRNSTotal Voting Rights
30th Apr 202611:15 amRNSResult of AGM
30th Apr 20267:00 amRNSHammerson CFO to retire
29th Apr 20267:00 amRNSHolding(s) in Company
28th Apr 20263:00 pmRNSDirector/PDMR Shareholding
24th Apr 20261:30 pmRNSEMTN Programme: Publication of Base Prospectus
24th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSHolding(s) in Company
8th Apr 20264:00 pmRNSDirector/PDMR Shareholding
7th Apr 202612:45 pmRNSTotal Voting Rights and Capital
30th Mar 202610:00 amRNSDirector/PDMR Shareholding
26th Mar 202611:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Mar 20262:00 pmRNSDirector/PDMR Shareholding
17th Mar 202610:00 amRNSDirector/PDMR Shareholding
17th Mar 20269:00 amRNSDividend Currency Conversion Announcement
25th Feb 20267:01 amRNSDividend Declaration
25th Feb 20267:00 amRNSFinal Results
6th Feb 20267:00 amRNSDirectorate change
28th Jan 20269:00 amRNSNotice of Results
20th Jan 20263:30 pmRNSHolding(s) in Company
22nd Dec 202511:30 amRNSDirector/PDMR Shareholding
22nd Dec 20259:30 amRNSDirector/PDMR Shareholding
15th Dec 20253:00 pmRNSDirector/PDMR Shareholding
11th Dec 20252:15 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSDirectorate change
21st Nov 20257:00 amRNSAcquisition of The Oracle and Trading Update
13th Nov 20251:45 pmRNSDirector/PDMR Shareholding
31st Oct 20257:45 amRNSResults of Dividend Reinvestment Plan
28th Oct 20251:00 pmRNSDirector/PDMR Shareholding
24th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 202511:00 amRNSDirector/PDMR Shareholding
22nd Oct 20254:30 pmRNSDirector/PDMR Shareholding
21st Oct 202512:00 pmRNSDirector/PDMR Shareholding
16th Oct 20251:00 pmRNSPublication of Final Terms
9th Oct 20257:00 amRNSBond Pricing, Guidance & Operational Update
25th Sep 20254:30 pmRNSHolding(s) in Company
19th Sep 20253:30 pmRNSDirector/PDMR Shareholding
11th Sep 20254:45 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNSAppointment of Rob Wilkinson as CEO
4th Sep 20253:30 pmRNSPublication of Supplementary EMTN Prospectus
29th Aug 202512:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.